Bioqual, Inc. Bioqual, Inc.

Bioqual, Inc.

BIOQ

Rank in Stocks #24892
Bioqual, Inc. delivers a range of preclinical research solutions, encompassing... Bioqual, Inc. delivers a range of preclinical research solutions, encompassing both in-vivo and in-vitro methodologies, to its diverse clientele of commercial enterprises and government agencies across the United States. Their expertise spans numerous critical health domains, including investigations into COVID-19, AIDS, influenza, RSV infection, and various flaviviruses such as Zika and Dengue. Furthermore, their work extends to malaria, hepatitis, and oncology. The firm's comprehensive laboratory capabilities further include processing biological samples, producing virus stocks, precisely quantifying infectious viral loads, and conducting assays like virus neutralization and hemagglutination inhibition. They also utilize advanced techniques such as quantitative PCR, ELISA for antigen and antibody detection, flow cytometry, lymphocyte proliferation studies, and various other cell-based analytical methods. Moreover, Bioqual furnishes specialized support for studies employing animal research models. Established in 1981, Bioqual, Inc. maintains its primary operational base in Rockville, Maryland.
Share Price
$31.00
Last synced: 2026-11-17
Market Cap
$27.73M
Change (1 day)
0.00%
Change (1 year)
-19.50%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for Bioqual, Inc. (BIOQ)
EPS as of August 2026 TTM: $-4.93
According to Bioqual, Inc.'s latest financial reports, its current EPS (TTM) is $-4.93. At the end of 2025 the company had an EPS of $-1.17, a decrease compared to its 2024 EPS of $0.54.
EPS history for Bioqual, Inc. from 2001 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-4.93 321.37%
2025 $-1.17 -316.67%
2024 $0.54 -41.94%
2023 $0.93 -84.18%
2022 $5.88 -16.95%
2021 $7.08 49.37%
2020 $4.74 49.53%
2019 $3.17 -22.68%
2018 $4.10 -7.66%
2017 $4.44 37.89%
2016 $3.22 51.17%
2015 $2.13 119.59%
2014 $0.97 -1,070.00%
2013 $-0.10 -122.22%
2011 $0.45 -2.17%
2010 $0.46 -61.98%
2007 $1.21 39.08%
2006 $0.87 1.16%
2005 $0.86 11.69%
2004 $0.77 28.33%
2003 $0.60 87.50%
2001 $0.32 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$18.99 -485.19%
US
$6.12 -224.14%
US
$1.38 -127.91%
CN
$14.91 -402.43%
US
$5.09 -203.25%
US

Questions about Bioqual, Inc.'s earnings per share (EPS)

What is Bioqual, Inc.'s earnings per share (EPS)?

Bioqual, Inc.'s earnings per share (EPS) over the last twelve months is $-4.93, as of Aug 2026.

What was Bioqual, Inc.'s earnings per share (EPS) in 2025?

In 2025, Bioqual, Inc.'s earnings per share (EPS) was $-1.17, compared with $0.54 in 2024.

How has Bioqual, Inc.'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, Bioqual, Inc.'s earnings per share (EPS) was highest in 2021 ($7.08) and lowest in 2025 ($-1.17).

How does Bioqual, Inc.'s earnings per share (EPS) compare with similar companies?

Bioqual, Inc.'s earnings per share (EPS) ($-4.93) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.